USPTO serial 79406268
PRUFIBRY
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Sep 2, 2025
- Examiner
- PARKER, JUSTINE D
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with PRUFIBRY?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Garth M. Dahlen
Garth M. Dahlen Mendelsohn Dunleavy, P.C.1500 John F. Kennedy Blvd.Two Penn Center, Suite 910Philadelphia, PA 19102Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Biological preparations for use in industry and science, namely proteins and protein preparations derived from human blood, blood plasma, or blood serum, coagulation factors; biological preparations, namely plasma and serum preparations for cultivating cells, tissue, or organs for industrial and scientific purposes. | ACTIVE | — |
| 005 | Pharmaceutical, medical and veterinary preparations for hematology, for intensive care medicine, for transplantation medicine, for oncology, for influencing blood diseases, and for influencing blood coagulation; blood products, blood substitute, and blood plasma substitute for medical purposes; blood serums preparations for medical purposes, in particular those containing serum proteins and related solutions; pharmaceutical proteins and medical protein preparations made from human blood, blood plasma and blood serum for hematology, for intensive care medicine, for transplantation medicine, for oncology, for influencing blood diseases, and for influencing blood coagulation; pharmaceutical preparations in the nature of human coagulation factors for hematology, for intensive care medicine, for transplantation medicine, for the treatment of oncology, for influencing blood diseases, and for influencing blood coagulation; fibrinogen and fibrinogen made from human blood plasma, in the nature of pharmaceutical preparations for hematology, for intensive care medicine, for transplantation medicine, for the treatment of oncology, for influencing blood diseases, and for influencing blood coagulation; pharmaceutical and veterinary products for hematology, intensive care medicine, transplantation medicine, oncology, for influencing blood diseases, and for influencing blood coagulation | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Apr 9, 2026 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Mar 26, 2026 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Mar 19, 2026 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Mar 19, 2026 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Mar 9, 2026 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Mar 9, 2026 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Dec 2, 2025 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Sep 2, 2025 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Sep 2, 2025 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jul 15, 2025 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jul 15, 2025 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 9, 2025 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jun 11, 2025 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 11, 2025 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jun 11, 2025 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jun 11, 2025 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jun 11, 2025 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Apr 17, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 17, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 17, 2025 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 17, 2025 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Apr 17, 2025 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 17, 2025 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Apr 17, 2025 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Apr 17, 2025 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Nov 17, 2024 | RFNT | REFUSAL PROCESSED BY IB | — |
| Oct 30, 2024 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Oct 30, 2024 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Oct 25, 2024 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Oct 24, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 17, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 11, 2024 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Oct 11, 2024 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 10, 2024 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |